US Updates Cervical Cancer Screening Guidelines with Self-Collection

Federal health officials have unveiled updated guidelines for cervical cancer screening that introduce self-collection options for HPV testing and eliminate patient costs, aiming to boost participation among women who face access barriers. The Health Resources and Services Administration, part of the US Department of Health and Human Services, released the recommendations in late 2025, with insurance coverage requirements taking effect on January 1, 2027.

The guidelines target average-risk women aged 21 to 65 and prioritize high-risk human papillomavirus testing as the primary method for those 30 to 65. For this age group, screening every five years can involve clinician-collected samples, co-testing with cytology and HPV, or cytology alone every three years if HPV testing is unavailable. A key addition allows women 30 to 65 to self-collect vaginal samples using FDA-approved kits, either at home or in a clinical setting, for HPV analysis. Women aged 21 to 29 should continue with cytology-based screening every three years, as co-testing is not advised for them due to lower risk.

These changes build on decades of progress in cervical cancer prevention. Widespread screening has...